Skip to main content
OpenTrials

Clinical trial condition

Biliary Tract Diseases

Explore clinical trials studying Biliary Tract Diseases. Study availability and eligibility vary by location and protocol.

1,498 public trials 302 recruiting studies
Refine in advanced search Browse all conditions

Biliary Tract Diseases trial results

Active, Not Recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

NCT03257761

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

NCT06465563

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +4 more
Locations
  • Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University) Nanjing, Jiangsu, China
  • The First Affiliated Hospital，Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336

Conditions
Advanced MTAP-null Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • California Research Institute Glendale, California, United States
  • Fomat Medical Research Oxnard, California, United States
  • University of California at SF San Francisco, California, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

NCT06188702

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +12 more
Locations
  • Lake Mary Cancer Center - Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

NCT03875235

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

NCT04042831

Conditions
Bile Duct Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

NCT05506943

Conditions
Adenocarcinoma, Ampullary Cancer, Biliary Tract Cancer, +13 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Medicine Cancer Center Palo Alto, California, United States
View all 34 locations
View Trial Details

Related conditions